Abstract
Pulmonary embolism (PE) is a major international health problem, with an annual estimated incidence of over 100,000 cases in France, 65,000 cases among hospitalized patients in England and Wales, and at least 60,000 new cases per year in Italy. The diagnosis is often untreated, difficult to obtain and is frequently missed [1]. Mortality in the untreated is approximately 30%, but with adequate treatment this can be reduced to 2–8%. Numerous cases go unrecognized and hence untreated, with poor outcomes. Indeed the prevalence of PE at autopsy (approximately 12–15% in hospitalized patients) has not changed over three decades [2].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
(2000) Task force on Pulmonary Embolism. European Society of Cardiology. Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heat J 21:1301–1336
Stein PD, Henry JW (1995) Prevalence of acute pulmonary embolism among patients in a general hospital at autopsy. Chest 108:78–81
Morpurgo M, Rustici A (1988) Lo spettro dell’embolia polmonare. Cardiologia 33:1105–1108
Morpurgo M, Schmid C (1980) Clinic-pathologic correlations in pulmonary embolism: a posteriori evaluation. Prog Res Dis 13:8–15
Pacouret G, Alison D, Pottier JM et al (1997) Free-floating thrombus and embolic risk in patients with angiographically confirmed proximal deep venous thrombosis: a prospective study. Arch Intern Med 157:305–308
Barrit DW, Jordan SC (1961) Clinical features of pulmonary embolism. Lancet 1:729–739
Goldhaber SZ, Hennekens CH, Evans D et al (1982) Factors associated with corrected antemortem major of pulmonary embolism. Am J Med 73:822–826
Kasper W, Konstantinides S, Tiede N et al (1997) Prognostic significance of right ventricular afterload stress detected by echocardiography in patient with clinically suspected pulmonary embolism. Heart 77:346–349
Ribeiro A, Lindmarker P, Jublin-Dannfelt A et al (1997) Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality. Am Heart J 134:479–487
Konstantinides S, Geribel A, Kasper W et al (1988) Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism. Circulation 97:1946–1951
Sasahara AA, Maclntyre KM, Cella G et al (1988) The clinical and the hemodynamic feature of pulmonary embolism. Curr Pulmonol 9:305–346
Kenneth E, Wood DO (2002) Review of a pathophysiologic apport to the golden hour of hemodynamically significant pulmonary embolism. Chest 121:877–905
McIntyre KM, Sasahara AA (1974) Determinants of right ventricular function and haemodynamics after pulmonary embolism. Chest 65:534–643
Mclntyre KM, Sasahara AA (1974) Hemodynamic and ventricular responses to pulmonary embolism. Prog Cardiovasc Dis 17:175–190
Benis CE, Serur JR, Borkenaghen D et al (1974) Influence of right ventricular filling pressure on left ventricular pressure and dimission. Circ Res 34:498–504
Menzel T, Wagner S, Kramm T et al (2000) Pathophysiology of impaired right and left ventricular function in chronic embolic pulmonary hypertension. Chest 118:897–903
Belenkie I, Dani R, Smith ER, Tyberg JV (1988) Ventricular interaction during experimental acute pulmonary embolism. Circulation 78:761–768
Adam JE, Siegel BA, Goldstein et al (1992) Elevation of CK-MB following pulmonary embolism. Chest 101:1203–1236
Ramirez-Rivera A, Gutiérrez-Fajardo P, Jerjez-Sanchez C et al (1993) Acute right myocardial infarction without significant obstructive coronary lesions secondary to massive pulmonary embolism. Chest 104:80S
Konstantinides S, Geibel A, Olschewski M et al (2002) Importance of toponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 106:1263–1268
Manier G, Castaing Y, Guenard H (1985) Determinants of hypoxemia during the acute phase of pulmonary embolism in humans. Am Rev Respir Dis 132:332–338
Krivec B, Voga G, Zuran I et al (1997) Diagnosis and treatment of shock due to massive pulmonary embolism. Approach with transesophageal echocardiography and intrapulmonary thrombolysis. Chest 112:1310–1316
Palla A, Petruzzelli S, Donnamaria V et al (1995) The role of suspicion in the diagnosis of pulmonary embolism. Chest 107:21S–24S
Kohen H, Koenig B, Mostbeck A (1987) Incidence and clinical feature of pulmonary embolism in patients with deep vein thrombosis: a prospective study. Eur J Nucl Med 13:S11–S15
Kakkar VV, Flanc C, Howe CT, Clarke MB (1969) Natural history of postoperative deep-vein thrombosis. Lancet 2:230–232
Mathru M, Venus B, Smith R et al (1986) Treatment of low cardiac output complicating acute pulmonary hypertension in normovolemic goals. Crit Care Med 14:120–124
Ducas J, Prewitt RM (1987) Pathophysiology and therapy of right ventricular dysfunction due to pulmonary embolism. Cardiovasc Clin 17:191–202
Prewitt RM (1997) pharmacological hemodynamic support in massive pulmonary embolism. Chest 111:218–224
Mercat A, Diehl JL, Meyer G et al (1999) Hemodynamic effects of fluid loading in acute massive pulmonary embolism. Crit Care Med 27:540–544
Ghignone M, Girling L, Prewitt RM (1984) Volume expansion versus nore-phinephrine in treatment of a low cardiac output complicating an acute in righr ventricular afterloads in dogs. Anesthesiology 80:132–135
Molloy DW, Lee KY, Jones D et al (1985) Effects of noradrenaline and isoproterenol on cardio-pulmonary function in a canine model of acute pulmonary hypertension. Chest 88:432–435
Angle MH, Molloy DW, Penner B et al (1989) The cardiopulmonary and renal hemo-dynamc effects of norephinephrine in canine pulmonary embolism. Chest 95:1333–1337
Wolfe MW, Saad RM, Spence TH (1992) Hemodynamic effects of amrinone in a canine model of massive pulmonary embolism. Chest 102:274–278
Hill NS, Rounds S (1983) Amrinone dilates pulmonary vessels and blunts hypoxic vasoconstriction in isolated rat lungs. Proc Soc Exp Biol Med 173:205–212
Manier G, Castaing Y (1992) Influence of cardiac output on oxygen exchange in acute pulmonary embolism. Am Rev Respir Dis 145:130–136
Jardin F, Genevray B, Brun-Neg D et al (1985) Dobutamine: a hemodynamic evaluation in pulmonary embolism shock. Crit Care Med 13:1009–1012
Layish DT, Tapson VF (1997) Pharmacological hemodynamic support in massive pulmonary embolism. Chest 111:218–224
Triantafillou AN, Pohl MS, Okabayashi K et al (1995) Effect of inhaled nitric oxide and prostaglandin E1 on hemodynamic and arterial oxygénation in patients following single lung transplantation. Anesth Analg 8o:SCA 40
Walmrath D, Schermuly R, Pilch J et al (1997) Effect of inhaled versus intravenous vasodilators in experimental pulmonary hypertension. Eur Respir J 10:1084–1092
Brienza A (1999) Strategies on management of pulmonary hypertension. Minerva Anestesiol 65:769–773
Capellier G, Jacques T, Balay P et al (1997) Inhaled nitric oxide in patients with pulmonary embolism. Intensive Care Med 1089–1092
Vizza CD, Della Rocca G, Di Roma A et al (2001) Acute hemodynamic effects of inhaled nitric oxide, dobutamine and a combination of two in patients with mild to moderate secondary pulmonary hypertension. Critical Care 5:355–361
Haraldsson A, Kieler-Jensen N, Ricksten SE et al (1996) Inhaled prostcyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: a pharmacodynamic study. J Cardiothorac Vasc Anesth 10:864–868
Olschewski H, Gofrani HA, Walmarath D et al (1999) Inhaled prostcyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis. Am J Respir Crit Care Med 160:600–607
Mirza I, Nagamine J, Pearl RG (1997) Additive effects of inhaled prostacyclin and inhaled nitric oxide in reducing experimental pulmonary hypertension. Anesthesiology 87:1122
Hill LL, Pearl RG (1999) Combined inhaled nitric oxide and inhaled prostacyclin during experimental chronic pulmonary hypertension. J Appl Physiol 86:1160–1164
Della Rocca G, Coccia C, Pompei L et al (2001) Hemodynamic and oxygenation changes of combined therapy with inhaled nitric oxide and inhaled areosolized prostacyclin. J Cardiothorac Vasc Anesth 15:224–227
Ginsberg JS (1996) Management of venous thromboembolism. N Engl J Med 335:1816–1828
Goldhaber SZ (1998) Pulmonary Embolism. New Engl J Med 339:93–104
Hyers TM, Russell DH, Weg JG (1995) Antithrombotic therapy for venous throm-boembolic disease. Chest 108:335S-351S
Shulman S, Rhedin AS, Lindmarker P et al (1995) A comparison of six weeks with six months of oral anticoagulation therapy after a first episode of venous thrrom-boembolism. N Eng J Med 332:1661–1665
Ahearn GS, Hadjiadis D, Govert JA et al (2002) Massive pulmonary embolism during pregnancy succesfully treated with recombinant tissue plasminogen activator. A case report and review of treatment options. Arch Int Med 162:1221–1227
Hamel E, Pacouret G, Vinentelli D et al (2001) Thrombolysis or heparin therapy in massive pulmoanry embolism with right ventricular dilation. Chest 120:120–125
Konstantinides S, Geibel A, Olschewski M et al (1997) Association between throim-bolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism. Circulation 96:882–888
Arcaoy Sm, Kreit JW (1999) Thrombolytic therapty of pulmonary embolism. Chest 115:1695–1707
Sors H, Pacouret G, Azarian R, Meyer G et al (1994) Hemodynamic effects of bolus vs 2-h infusion of alteplase in acute massive pulmonary embolism. A randomized controlled multicenter trial. Chest 106:712–717
Wood KE (2002) Major pulmonary embolism. Review of a patophysiologic approach to the Golden Hour of hemodynamically significant pulmoanry embolism. Chest 121:877–905
Girard P, Stern JB, Parent F (2002) Medical literature and the Vena Cava filters. Chest 122:963–967
(1999) Participants in the Vena Cava Filter Consensus Conference. Recommended reporting standards foe vena cavai filter placement and patients follow-up. J Vasc Surg 30:573–579
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Italia
About this chapter
Cite this chapter
Della Rocca, G., Coccia, C., Reffo, I. (2004). Acute Pulmonary Embolism: Hemodynamic Aspects and Treatment. In: Gullo, A., Berlot, G., Lucangelo, U., Pellis, T. (eds) Perioperative and Critical Care Medicine. Springer, Milano. https://doi.org/10.1007/978-88-470-2135-8_16
Download citation
DOI: https://doi.org/10.1007/978-88-470-2135-8_16
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0278-4
Online ISBN: 978-88-470-2135-8
eBook Packages: Springer Book Archive